Spots Global Cancer Trial Database for snk02
Every month we try and update this database with for snk02 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy | NCT05990920 | Pathologically ... Refractory Canc... Metastatic Canc... Recurrent Cance... Solid Tumor, Ad... Solid Tumor Advanced Cancer Advanced Solid ... | SNK02 | 18 Years - | NKGen Biotech, Inc. |